Article metrics

Extended report
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
Free

 

Online download statistics by month:

Online download statistics by month: September 2015 to August 2023

AbstractFullPdf
Sep 2015125091191
Oct 20151223342
Nov 2015893028
Dec 2015871819
Jan 20162587292400
Feb 20161443210253
Mar 201648679104
Apr 20163555884
May 20162165255
Jun 20161454653
Jul 20161547376
Aug 20161065139
Sep 20161295048
Oct 20161376456
Nov 20161007261
Dec 2016795144
Jan 2017915141
Feb 2017446137
Mar 2017455453
Apr 2017124431
May 2017167139
Jun 2017215230
Jul 2017795426
Aug 2017693918
Sep 2017705827
Oct 20171006832
Nov 20171166951
Dec 20171076023
Jan 20181107532
Feb 2018986338
Mar 2018714434
Apr 20181389556
May 201816012924
Jun 2018776223
Jul 2018998322
Aug 20181058618
Sep 2018938624
Oct 20181027430
Nov 201814211842
Dec 20181048613
Jan 20191008241
Feb 2019776815
Mar 2019645526
Apr 2019574525
May 2019555039
Jun 2019715538
Jul 2019776541
Aug 2019393518
Sep 2019614629
Oct 2019756127
Nov 2019645237
Dec 2019695137
Jan 2020524831
Feb 202011810928
Mar 2020594535
Apr 2020625250
May 2020635340
Jun 2020574927
Jul 2020533914
Aug 2020433635
Sep 2020674326
Oct 2020453218
Nov 2020675043
Dec 2020976034
Jan 2021746039
Feb 2021796845
Mar 2021645328
Apr 2021666035
May 20211007040
Jun 2021606039
Jul 2021535340
Aug 2021434325
Sep 2021676534
Oct 2021514828
Nov 2021746751
Dec 2021605323
Jan 2022938435
Feb 2022706931
Mar 2022756933
Apr 2022584724
May 2022736352
Jun 2022968941
Jul 2022847421
Aug 20221036820
Sep 202213210543
Oct 20221068228
Nov 2022817822
Dec 2022938716
Jan 2023816631
Feb 202312710928
Mar 2023969234
Apr 20231208946
May 2023957823
Jun 2023676125
Jul 2023705430
Aug 2023927828
Total1374964754109